[Activation in the metaloproteinases complex in the follicle-embryonic generative capability]

Gerardo Barroso1, Clara Corona de Lau, Julio González

  • 1Unidad de Reproducción Asistida, Departamento de Ginecología y Obstetricia, Clínica Lomas Altas, México, DF.

Abstract

Insights

The study found that the tissue inhibitor of metalloproteinase (TIMP) to matrix metalloproteinase-3 (MMP-3) complex concentration decreases with age, impacting ovular quality and embryonic development in women undergoing in vitro fertilization.

Area of Science:

  • Reproductive Endocrinology
  • Biochemistry
  • Infertility Research

Context:

  • In vitro fertilization (IVF) cycles are crucial for assisted reproduction.
  • Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play roles in tissue remodeling, including ovarian function.
  • Understanding the TIMP/MMP complex in stimulated cycles is vital for improving IVF outcomes.

Purpose:

  • To investigate the impact of the tissue inhibitor of metalloproteinase (TIMP) to matrix metalloproteinase-3 (MMP-3) complex on follicle development and subsequent ovule and embryonic development during stimulated IVF cycles.
  • To correlate TIMP/MMP-3 concentrations with patient age and ovarian stimulation parameters.

Summary:

  • This prospective longitudinal study evaluated 20 patients undergoing IVF.
  • Matrix metalloproteinase concentrations in serum and follicular fluid were measured during stimulation and retrieval.
  • A positive correlation was observed between basal FSH and patient age (r2 = 0.26, p = 0.003).
  • Significant differences in MMP concentrations were found between age groups (<35 vs. >35 years).
  • The TIMP/MMP-3 complex concentration decreased by 14% with increasing female patient age.

Impact:

  • The study highlights the role of the TIMP/MMP-3 complex in assessing ovular quality and embryonic development.
  • Findings suggest that age-related changes in MMP complex influence IVF success.
  • This research provides insights into biomarkers for predicting reproductive outcomes in assisted reproduction technologies.

Related Concept Videos

Folliculogenesis01:20

Folliculogenesis

Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
Fertilization01:38

Fertilization

During fertilization, an egg and sperm cell fuse to create a new diploid structure. In humans, the process occurs once the egg has been released from the ovary, and travels into the fallopian tubes. The process requires several key steps: 1) sperm present in the genital tract must locate the egg; 2) once there, sperm need to release enzymes to help them burrow through the protective zona pellucida of the egg; and 3) the membranes of a single sperm cell and egg must fuse, with the sperm...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Cleavage and Blastulation01:33

Cleavage and Blastulation

After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...